Information Provided By: 
Fly News Breaks for May 9, 2018
TRHC
May 9, 2018 | 05:28 EDT
Piper Jaffray analyst Sean Wieland believes Tabula Rasa HealthCare is in the "right place at the right time" as the dialogue around pharmacy risk is accelerating. The focus is on executing in the health plan market, and delivering a needed capability to address the opiod crisis, Wieland tells investors in a post-earnings research note. He raised his price target for the shares to $46 and reiterates an Overweight rating on Tabula following its Q1 results.
News For TRHC From the Last 2 Days
There are no results for your query TRHC
